Eli Lilly & Co. (LLY) Tops Q3 EPS by $1.88, Beats on Revenue; Offers FY26 Guidance
Get Alerts LLY Hot Sheet
Price: $1,369.34 +6.29%
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
MGYR, EACO, FMBH, More
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
MGYR, EACO, FMBH, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $7.48, $1.88 better than the analyst estimate of $5.60. Revenue for the quarter came in at $24.4 billion versus the consensus estimate of $22.42 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2026 EPS of $35.00-$36.00, versus the consensus of $34.46. Eli Lilly & Co. sees FY2026 revenue of $91-92 billion, versus the consensus of $88.7 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Magyar Bancorp (MGYR) Tops Q4 EPS by 52c
- Eaco Corporation (EACO) reported Q4 result
- Visa stock continues higher post results, MasterCard strength
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share